Tamm-Horsfall protein (THP) is the most abundant protein in normal urine, and the constituent of all tubular casts [1] [2] [3] . Its synthesis and membrane expression by cells of the thick ascending limb of the loop of Henle have led to the suggestion that it might be involved in ion transfer [3, 4] . Recently Hoyer et al [5] [6] [7] reported experimental studies demonstrating the pathogenic role of active or passive anti-THP immunization. However, the precise functions of THP and its role in human pathology, although likely, are yet undefined. Further studies, including analysis of extra-renal distribution and measurement in body fluids (8) (9) (10) (11) (12) , remain difficult partly because of the lack of reliable immunological reagents. This led us to undertake the production of monoclonal antibodies (Mab) specific for human THP. We report here on the characterization of the specificities obtained and their use to develop an immunoenzymoassay (lEA) and to demonstrate the presence of THP in serum.
Methods

Preparation of human Tamrn-Horsfall protein
Tamm-Horsfall protein was prepared from normal human urine by precipitation with 0.58 M NaCI as previously described [2] . Purity was assessed by polyacrylamide gel electrophoresis in the presence of SDS (PAGE-SDS) [13] .
Production of monoclonal antibodies
Monoclonal antibodies were prepared according to methods previously described [14, 15] . Supernatants were screened for the presence of anti-THP antibodies by indirect immunofluo-© 1986 by the International Society of Nephrology rescence (hF) on frozen kidney sections and by lEA using THP (200 ng in 200 piiter of carbonate bicarbonate buffer, pH 9.4) adsorbed to plastic wells of microtiter plates (Nunc) by incubation for three hr at 37°C. After washing with PBS Tween 0.05% (PBST), the wells were incubated for two hr at room temperature with 100 piiter of supernatant diluted one-half in PBST, washed and incubated with peroxidase labeled sheep antimouse IgG [15] . Enzyme activity was revealed with Orthophenylenediamine (OPD). All supernatants considered as positive reacted in the LEA and gave by hF the typical pattern previously described [3] . Cell cloning, class and subclass determination of the Mab, purification and labeling with biotin were performed as previously described [14] [15] [16] .
Spec(/iciiy analysis of the Mab. In order to individualize the epitopes identified by the various Mab, binding of a given biotin labelled Mab (B-Mab) to solid phase THP was assessed in the absence or in the presence of the Mab to be tested. Plastic wells on which THP had been adsorbed as described above were incubated with 100 .diter of supernatant or serial dilutions to l0) in PBST of the ascites containing the Mab analyzed, immediately followed by B-Mab (0.1 g/mliter) in PBST. Binding was compared to that observed with B-Mab diluted in PBST only. Control experiments were performed with myeloma proteins devoid of known antibody specificity. In all cases, solid phase associated B-Mab was detected and quantified using peroxidase labelled avidin (Vector Laboratories, Compiègne, France) diluted 1/3000 in 50 m phosphate buffer pH 8.0 containing 0.5 M NaC1 and 0.5% Tween 20.
The ability to bind radiolabelled human THP was tested for all Mab. THP was labelled with 125! by the chloramine T method as described by Hartmann et al [17] Detection of THP in normal hutnan serum
The assay was used to demonstrate the presence of immunoreactive THP in fresh human serum. In initial experiments, tenfold serial dilutions of normal human serum were introduced in the capture lEA described above. In order to confirm the specificity of the binding observed, 10 muter of human serum were passed over a 0.5 mliter column of Sepharose 4B (Pharmacia, Velizy, France) coupled to a monoclonal anti-THP antibody (Mab 174) at a concentration of 10 mg/mliter according to manufacturer's instructions. After thorough washing, the bound material was eluted with either alkaline buffer [18] , or SDS containing sample buffer [13] and dialysed against distilled water. The reactive material diluted in PBST containing 0.005% SDS was assayed using various combinations of capture and detection antibodies to determine whether the different epitopes defined on urinary THP were detectable on the immunoreactive material. In some experiments, in order to assess the molecular wt of the reactive protein, the SDS-eluted material was separated by PAGE-SDS [13] and transferred to nitrocellulose sheets [19] . The latter were revealed with B-Mab anti-THP followed by peroxidase labelled avidin. Peroxidase reaction product was detected using 4-chloronaphtol. Control experiments were performed using Sepharose 4B coupled to MOPC 173, a monoclonal mouse lgG devoid of known antibody specificity. The eluates were analyzed by lEA and immunoblotting in the same fashion as described above. In addition, whole human serum and urine samples were submitted to PAGE-SDS and analyzed by immunoblotting.
Fractionation of THP from normal urine by affinity chro,natography. Two hundred muter of fresh normal urine collected in the presence of sodium azide were incubated overnight at 4°C with 5 mli(er of S4B coupled to a Mab anti-THP. After thorough washing, the bound material was eluted as above, concentrated by lyophilisation, and analyzed by PAGE-SDS. 
Results
Production of monoclonal anti-THP antibodies
Two hundred and forty of the 300 seeded wells contained hybrids, 43 of which secreted antibody reactive with renal tissue. Fifteen reacted with THP by immunoenzymoassay and indirect immunofluorescence on frozen kidney sections. The 28 remaining antibodies did not react with THP but were able to bind various renal structures including proximal tubule brush border.
Specificity of inonoclonal anti-THP antibodies
In order to analyze the fine specificity of the anti-THP antibodies, the first two antibodies which were cloned, Mab 18 and Mab 174, were purified and labelled with biotin. No cross inhibition was found when the binding of each of these B-Mab to solid phase THP was studied in the presence of the other Mab, thus indicating that the two Mab were directed against distinct epitopes. At this stage, supernatants from each of the hybrids obtained were tested for their ability to inhibit binding of the two B-Mab. Supernatants which did not inhibit binding in any of the two systems were considered as defining a new epitope. The corresponding cells were cloned, and the Mab so produced was purified, labelled with biotin and added to the original panel. The selection process was then repeated with the new extended panel. Table I Most epitopes identified by the Mab were specific for human THP. Mab 214 however reacted with rabbit and rat THP. Mab 195 displayed reactivity for rat THP only, Mab 89 and 174 for rabbit THP only.
Development of an immunoenzymoassay for THP
The specificity analysis was used to set up a capture lEA.
Mab 89 and 104 were first adsorbed to plastic wells which were subsequently incubated with THP containing solutions. After washing the wells were incubated with B-Mab 174 and B-Mab 18. The assay was very reproducible, as shown in Figure 2 which depicts means SD of all optical densities measured when serial twofold dilutions of THP were used to construct standard curves over a period of three months. Specificity of the assay was demonstrated by the lack of binding when the anti-THP antibodies adsorbed to the wells were omitted (MOPC 173 coated wells). Sensitivity of the assay allowed detection of THP concentrations as low as 1 nglmliter. In order to compare reactivity of THP under various conditions, binding curves were constructed using serial two fold dilutions of reference purified THP and unfractionated urine. The slopes of the linear segments (r < 0.995) were not statistically different. Intra-and interassay coefficients of variation are respectively 10% and 13%.
Detection of THP in normal serum As illustrated in Figure 3 , the lEA was used to detect the presence of THP in serum. Levels measured varied from 5 to 50 ng/mliter. Using various combinations of capture and detection Mab, it was possible to demonstrate (Fig. 4) that all the five epitopes tested, initially identified on urinary THP, were present on the immunoreactive material prepared from serum. The lEA was used to construct binding curves with serial twofold dilutions of the reference THP and of the material eluted from S4B-Mab 174. The slopes of the linear segments of the two In order to assess the molecular wt of the immunoreactive material present in serum, material eluted from the immunoadsorbent with SDS buffer was submitted to PAGE-SDS, transferred to nitrocellulose sheets and revealed using B-Mab. Preliminary experiments demonstrated that THP prepared from normal urine and analyzed in the same manner was reactive with the various Mab: Mab 174 and 18 were the best reactors and Mab 89 the poorest. As shown in Figure 5 , it was possible using B-Mab 174 to identify clearly a major immunoreactive band comigrating with THP prepared from normal urine. No specific binding was found when normal human serum, or eluates from S4B-MOPC 173, were separated by PAGE-SDS and analyzed by immunoblotting with the various B-Mab. Preparation of urinary THP by affinity chromatography. As shown in Figure 6 , when the material eluted from Mab 174 or Mab 18 bound to Sepharose 4B was analyzed by PAGE-SDS, a single band comigrating with THP prepared by salt precipitation was obtained.
Discussion
The results presented in this paper show that a variety of Mab anti-human THP can be obtained. It is interesting to note that a Reactive material prepared from serum could be detected using all antibody combinations. Note lack of reactivity of wells coated with MOPC 173 (•).
number of Mab were produced to specificities unrelated to THP. This may be in relation with the ability of THP to bind unrelated proteins which may thus be present in the purified preparations. The specificity studies clearly indicate that the Mab individualize seven distinct epitopes. It cannot be ascertained whether Mab 174 and Mab 35 bind closely related epitopes with consequent steric hindrance, or whether they recognize the same epitope but with greater affinity for Mab 174. The latter hypothesis is difficult to reconcile with the fact that inhibition reaches a plateau at 50% when unlabelled inhibitor is increased over two orders of magnitude. The specificity of the Mab provides several informations on the immunological reactivity of THP. First, most of the Mab were unable to react with iodinated THP, suggesting that THP may be very sensitive to oxidative damage by chioramine T and/or introduction of iodine in the tyrosine residues. Second, some epitopes such as that defined by Mab 18 may be more immunogenic than others as indicated by the isolation of five reactive clones. Third, only a minority of Mab were able to react with antigenic determinants present in several species, suggesting that they might be less immunogenic.
The antibodies obtained were adequate to set up a capture lEA for THP. Such an assay had not been previously reported and was found to be as sensitive as the radioimmunoassays at present available . The reproducibility of the lEA and the indefinite availability of the reagents should be of assistance to standardize THP measurements already made difficult by the variability of THP reactivity [20] . The sensitivity of the assay was sufficient to study THP reactive material in normal human serum. Studies using polyclonal antisera suggested that THP was detectable in normal sera, but cross reactivity could not be excluded. In fact, this possibility was supported by PAGE-SDS analysis of the material purified by affinity chromatography which demonstrated [211 the presence of numerous proteins, none of which comigrating with purified THP. Using developments of the EIA described in this work, it could be shown that the reactive material detectable in normal human serum shares at least five different epitopes with urinary THP. Binding curves obtained with serum and urine-derived material were parallel suggesting identical reactivity. In addition, immunoblotting experiments established that the reactive material isolated from serum migrated on polyacrylamide gels with the expected molecular wt for THP, thus practically excluding cross reactivity. The development of a simple and reproducible TEA should allow further clinical studies of THP in renal pathology such as pyelonephritis [22] , tubulointerstitial diseases [24] [25] [26] , tubular obstruction [24] or transplant rejection [27] . The potential applications of the Mab reported are not limited to assays. Using immunoadsorption techniques, it has been possible to prepare THP by methods which do not involve high salt precipitation, and can be performed in a few hrs. Because the relations between structure and function are probably of primary importance, the specificity of the Mab may be of considerable value for further studies.
In conclusion, 15 Mab specific for TI{P have been produced. They define at least seven different epitopes and may be used for lEA and immunoaffinity purification. 
